Article

Maximize cancer patient care with IBA's expertise and ProteusONE's versatility

In the ever-evolving landscape of cancer treatment, how can cancer centers ensure they provide the most advanced proton therapy treatment and highest-quality patient care?

versatility

IBA is pioneering proton therapy around the world

The future of precision medicine is now more accessible than ever before. ​

​IBA has been contributing to cancer therapy innovations since its foundation in 1986 and has developed the most extensive network of proton therapy centers worldwide. IBA’s Proteus platform provides efficient proton therapy treatments, featuring streamlined workflows, and ground-breaking research capabilities, and has changed the lives of over 130,000 patients worldwide*.​

​IBA’s unequalled expertise in proton therapy and the unmatched versatility of ProteusONE help provide the most advanced proton therapy treatment, elevating the capabilities of cancer centers, enhancing patient care and contributing to placing cancer centers at the forefront of precision medicine for years to come.​

Mockup Expertise Versatility

Discover how IBA’s ProteusONE contributes to revolutionize cancer treatment and maximize patient care by downloading the Expertise and Versatility Solution Paper:​

Download access

Please fill in the form to download the document.

First name*
Last name*
Professional Email*
Job title*
Country*
Company*
Best
describes me*
IBA uses and stores cookies and other tracking technologies as specified in the IBA's Cookies Policy to improve your browsing experience on our website, and to understand where our visitors are coming from.

Your information will be collected, stored, and used according to IBA’s Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ProteusONE's versatility helps treat a broad mix of cancer indications

ProteusONE employs pencil beam scanning (PBS) to deliver intensity-modulated proton therapy (IMPT), a radiation oncology technique renowned for its precision in targeting tumor cells while minimizing radiation exposure to healthy tissue. This ground-breaking approach helps reduce unwanted side effects, lowering the risks of secondary cancers and improving patients’ quality of life.1-3​

​ProteusONE is capable of delivering non-coplanar treatment beams, providing additional degrees of treatment freedom, which is particularly useful in complex cases with irregular tumor anatomy and important sensitive organs at risk that need to be preserved. ProteusONE users also capitalize on the vertex beam delivery capabilities, essential for intracranial tumors.1,4​

​ProteusONE expands hospital’s treatment capabilities to more eligible patients, bringing them, and to the medical team, the benefits of the unparalleled precision of proton therapy.

PONE

ProteusONE provides fast treatment time and streamlined workflow

IBA's ProteusONE system offers streamlined workflows, empowering healthcare professionals to manage different treatment plans and cancer cases efficiently. Its open-gantry structure allows an easy combination of couch and gantry rotations, facilitating patient positioning and the treatment of complex irradiations. The system enables remote operation and imaging at the isocenter, contributing significantly to reduced treatment times. ​

​Designed with user comfort and efficiency in mind, ProteusONE facilitates high patient throughput with a LINAC-like workflow. By closely resembling the familiar LINAC workflow, ProteusONE ensures minimal disruption to existing practices while optimizing treatment quality and efficiency.

​Through its LINAC-like workflow, remotely operating capabilities, and imaging at the isocenter, ProteusONE helps achieve low treatment time per patient without compromising treatment quality.​

treatment quality

IBA ensures optimal integration and long-term excellence

From routine to research, ProteusONE offers unmatched flexibility for hospitals, allowing them to tailor their infrastructure and preferred partners to their specific cancer treatment needs. With its lifetime modularity, ProteusONE empowers healthcare providers to excel in their practice, offering precise proton therapy treatment options. Thanks to the synergy between IBA Proton Therapy and IBA Dosimetry, ProteusONE users also benefit from seamless integration, improved efficiency, and substantial time and quality gains during clinical commissioning and daily operations.​

​Integrating a proton therapy system like ProteusONE can transform a hospital's radiation oncology department through a positive ‘halo’ effect.  It can increase patient referrals, particularly for complex cases such as CNS or pediatric tumors, boost the number of patients treated, and increase proton therapy-related research projects and grant opportunities, enriching the institution's academic and clinical endeavours.5​

​Moreover, the installation of ProteusONE provides users with unmatched long-term value for the next 20+ years, both in terms of advanced features and high-quality patient care, as it is designed to be compatible with upcoming proton therapy innovations, such as DynamicARC and ConformalFLASH**.

Solution Paper Expertise Versatility

Download the Expertise and Versatility Solution Paper and discover how IBA’s ProteusONE contributes to revolutionize cancer treatment and maximize patient care:​

Download access

Please fill in the form to download the document.

First name*
Last name*
Professional Email*
Job title*
Country*
Company*
Best
describes me*
IBA uses and stores cookies and other tracking technologies as specified in the IBA's Cookies Policy to improve your browsing experience on our website, and to understand where our visitors are coming from.

Your information will be collected, stored, and used according to IBA’s Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Notes​
* Data from IBA & PTCOG - July 2023. ​
** ConformalFLASH® & DynamicARC® are registered brands of IBA’s Proton Therapy which are currently under research and development. ConformalFLASH® and DynamicARC® will be available for sale when regulatory clearance is received. Due to a continuous research and development program, IBA reserves the right to make changes in design, technical descriptions, and specifications of its products without prior notice. Some features are under development and may be subject to review by competent authorities. ​

​References​

  1. Hu M et al. Proton beam therapy for cancer in the era of precision medicine. J Hematol Oncol. 2018;11(1):136. ​
  2. Holliday EB et al. Proton Therapy Reduces Treatment-Related Toxicities for Patients with Nasopharyngeal Cancer: A Case-Match Control Study of Intensity-Modulated Proton Therapy and Intensity-Modulated Photon Therapy. Int J Part Ther. 2015;2(1):19–28. ​
  3. Yuan TZ et al. New frontiers in proton therapy: applications in cancers. Cancer Commun (Lond). 2019;39(1):61. ​
  4. Pugachev A et al. Role of beam orientation optimization in intensity-modulated radiation therapy. Int. J. Radiation Oncology Biol. Phys. 2001;50(2):551-560. ​
  5. Remick J et al. The downstream “halo” effect of a proton therapy center on an academic medical center. Int. J. Radiation Oncology Biol. Phys. 2019;104(4):756-764. 
On the same topic
MID127277

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Cookies policies